PyloGuard

PyloGuard™ is a dietary supplement  designed to support the body’s natural processes for elimination. It contains patented Lactobacillus reuteri DSM17648, which can attract specific
organisms in the intestine and support their removal via the digestive tract.

Description

PyloGuard™ is a dietary supplement  designed to support the body’s natural processes for elimination. It contains patented Lactobacillus reuteri DSM17648, which can attract specific
organisms in the intestine and support their removal via the digestive tract.

This particular strain of L. reuteri specifically binds to H. pylori in the stomach and supports overall digestive health.

Key Benefits

  • Supports bacteria levels in the stomach
  • Promotes the body’s process of elimination
  • Supports the microbiome
  • Maintains H pylori levels already within the normal range

Key Features

  • Lactobacillus reuteri DSM17648 culture containing ≥ 1 x1011 inactivated cells/gram
  • Produced in a low-temperature fermentation & drying process to avoid denaturing
  • Stable under the gastric conditions
  • Doesn’t disturb the gut microbial balance
  • Formulated in a free-flowing, spray-dried powder format
  • Stable at room temperature
  • Backed by in vitro and in vivo scientific research
  • Safe for long-term daily use (QPS, MIC, GRAS)
  • Produced and tested to exceed the most stringent EU quality standards (ISO)
  • Free from GMO, lactose, and fructose

Ingredients:

PyloGuard Ingredients

Other Ingredients: Nutriose® (corn dextrin), Natural Flavors, Vegetarian Capsule
(Cellulose, Water), Acacia Fiber.

Suggested Use:

Ages 9+: Open 1 capsule into 8 oz of water and drink once daily on an empty stomach. Children under the age of 9, please consult you

What is Helicobacter Pylori?

Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacterium native to the human gastrointestinal (GI) tract. It has an affinity for the acidic
environment of the gastric mucosa. Estimates say that up to 50% of the world’s population carries H. pylori in their GI tracts. H. pylori is spread through direct contact with
individuals or household pets through saliva, feces, or contaminated food or water. 1-3
Humanity’s relationship with H. pylori is ambiguous. H. pylori can have a commensal or symbiotic relationship with its human host.
H. pylori colonizes and multiplies in the duodenum and gastric mucosa, secreting urease, the enzyme that converts urea to ammonia. Alkaline ammonia buffers the
naturally low pH of the stomach, providing the optimal environment for H. pylori to live. 4,5

Disruption of the microbiome can cause occasional:

  • Nausea
  • Heartburn
  • Loss of appetite
  • Dyspepsia

 

FDA Statement: These statements have not yet been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.

 

Sources: 
1) Parikh, NS and Ahlawat, R. “Helicobacter Pylori.” In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 
   [Updated 2020 Aug 10]. Jan. 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534233/ 
2) Schulz, C et al. (2015), “H. pylori and other microbiota.” Journal of Digestive Diseases, 26 Jan. 2015. 
   https://onlinelibrary.wiley.com/doi/10.1111/1751-2980.12233
   https://www.karger.com/Article/Abstract/443353 
3) Kayali, S et al. “Helicobacter pylori, transmission routes and recurrence of infection: state of the art.”
   Acta bio-medica : Atenei Parmensis, vol. 89, no. 8-S, 2018. https://doi.org/10.23750/abm.v89i8-S.7947 
4) Kao, CY et al. “Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis.” 
   Biomed J., vol. 39, no. 1, Feb. 2016. https://pubmed.ncbi.nlm.nih.gov/27105595/ 
5) Figueiredo, C et al. “Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk 
   individuals for gastric carcinoma.” J Natl Cancer Inst., vol. 94, no. 22, 20 Nov 2002.
   https://pubmed.ncbi.nlm.nih.gov/12441323/ 
6) Abbas, M et al. “Prevalence and Associated Symptoms of Helicobacter pylori Infection among Schoolchildren 
   in Kassala State, East of Sudan.” Interdiscip Perspect Infect Dis., 15 Jan. 2018. 
   https://pubmed.ncbi.nlm.nih.gov/29568312/